Vincent R. Richard

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

5-Year Analysis, Breast Oncology, Oncology +10

Dynamics and regulation of lipid droplet formation in lipopolysaccharide (LPS)-stimulated microglia

Armen Khatchadourian, Simon D. Bourque, Vincent R. Richard et al. · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · 2012 · 140 citations

Inflammation, Molecular Physiology, Signal Transduction +9

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

Marco Colleoni, Weixiu Luo, Per Karlsson et al. · The Lancet Oncology · 2017 · 120 citations

Breast Oncology, Medicine, Cancer Management +7

Chemical genetic screen identifies lithocholic acid as an anti-aging compound that extends yeast chronological life span in a TOR-independent manner, by modulating housekeeping longevity assurance processes

Alexander A. Goldberg, Vincent R. Richard, Pavlo Kyryakov et al. · Aging · 2010 · 117 citations · Full text

Nosocomial bacteremia caused byBacillus species

Vincent R. Richard, P. Auwera, Robert Snoeck et al. · European Journal of Clinical Microbiology & Infectious Diseases · 1988 · 108 citations

Pathogenic Microbiology, Microbial Disease, Nosocomial Bacteremia +6